Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of antineoplaston therapy for Merkel cell carcinoma, islet cell carcinoma, neuroendocrine carcinoma, and pituitary tumors has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Islet Cell Carcinoma
• Merkel Cell Carcinoma
• Neuroendocrine Carcinoma
• Pituitary Tumor

Drugs mentioned

• Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Merkel Cell Carcinoma, Islet Cell Carcinoma | Phase 2 | Status: WITHDRAWN